GOLGA5
gene geneOn this page
Also known as ret-IIgolgin-84rfg5GOLIM5
Summary
GOLGA5 (golgin A5, HGNC:4428) is a protein-coding gene on chromosome 14q32.12, encoding Golgin subfamily A member 5 (Q8TBA6). Involved in maintaining Golgi structure.
The Golgi apparatus, which participates in glycosylation and transport of proteins and lipids in the secretory pathway, consists of a series of stacked cisternae (flattened membrane sacs). Interactions between the Golgi and microtubules are thought to be important for the reorganization of the Golgi after it fragments during mitosis. This gene encodes one of the golgins, a family of proteins localized to the Golgi. This protein is a coiled-coil membrane protein that has been postulated to play a role in vesicle tethering and docking. Translocations involving this gene and the ret proto-oncogene have been found in tumor tissues; the chimeric sequences have been designated RET-II and PTC5. A pseudogene of this gene is located on the short arm of chromosome 5.
Source: NCBI Gene 9950 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 110 total
- MANE Select transcript:
NM_005113
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4428 |
| Approved symbol | GOLGA5 |
| Name | golgin A5 |
| Location | 14q32.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ret-II, golgin-84, rfg5, GOLIM5 |
| Ensembl gene | ENSG00000066455 |
| Ensembl biotype | protein_coding |
| OMIM | 606918 |
| Entrez | 9950 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 14 protein_coding, 1 retained_intron
ENST00000163416, ENST00000554700, ENST00000555793, ENST00000868374, ENST00000868375, ENST00000868376, ENST00000868377, ENST00000868378, ENST00000868379, ENST00000868380, ENST00000868381, ENST00000868382, ENST00000868383, ENST00000868384, ENST00000868385
RefSeq mRNA: 1 — MANE Select: NM_005113
NM_005113
CCDS: CCDS9905
Canonical transcript exons
ENST00000163416 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000373020 | 92811551 | 92811754 |
| ENSE00000373024 | 92833122 | 92833347 |
| ENSE00000659881 | 92806736 | 92806963 |
| ENSE00000659882 | 92809300 | 92809519 |
| ENSE00000659883 | 92810254 | 92810377 |
| ENSE00000659891 | 92816251 | 92816421 |
| ENSE00000659892 | 92819708 | 92819836 |
| ENSE00000659893 | 92824546 | 92824644 |
| ENSE00000659895 | 92835559 | 92835664 |
| ENSE00000659896 | 92837386 | 92837449 |
| ENSE00000808700 | 92797408 | 92797981 |
| ENSE00001762532 | 92839366 | 92839947 |
| ENSE00002507040 | 92794305 | 92794456 |
Expression profiles
Bgee: expression breadth ubiquitous, 290 present calls, max score 96.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 26.4868 / max 215.6569, expressed in 1800 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 141146 | 24.8586 | 1796 |
| 141145 | 0.7157 | 455 |
| 141147 | 0.4804 | 285 |
| 141144 | 0.4320 | 209 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 96.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.58 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.34 | gold quality |
| parotid gland | UBERON:0001831 | 93.10 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 92.98 | gold quality |
| rectum | UBERON:0001052 | 92.86 | gold quality |
| skin of hip | UBERON:0001554 | 92.84 | gold quality |
| oocyte | CL:0000023 | 92.73 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.48 | gold quality |
| body of pancreas | UBERON:0001150 | 92.19 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 92.17 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.07 | gold quality |
| placenta | UBERON:0001987 | 92.05 | gold quality |
| pancreas | UBERON:0001264 | 92.01 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 91.51 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.41 | gold quality |
| nasopharynx | UBERON:0001728 | 91.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.37 | gold quality |
| colonic mucosa | UBERON:0000317 | 91.09 | gold quality |
| decidua | UBERON:0002450 | 91.09 | gold quality |
| liver | UBERON:0002107 | 91.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 91.01 | gold quality |
| jejunal mucosa | UBERON:0000399 | 91.00 | gold quality |
| oral cavity | UBERON:0000167 | 90.88 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 90.77 | gold quality |
| gingival epithelium | UBERON:0001949 | 90.76 | gold quality |
| lower lobe of lung | UBERON:0008949 | 90.75 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.74 | gold quality |
| gingiva | UBERON:0001828 | 90.72 | gold quality |
| gall bladder | UBERON:0002110 | 90.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting GOLGA5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
Literature-anchored findings (GeneRIF, showing 2)
- involved in generating and maintaining the architecture of the Golgi apparatus (PMID:12656988)
- Golgin-84 on coat protein I vesicles interacts with the conserved oligomeric Golgi complex before SNARE assembly. (PMID:20874812)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | golga5 | ENSDARG00000039279 |
| mus_musculus | Golga5 | ENSMUSG00000021192 |
| rattus_norvegicus | Golga5 | ENSRNOG00000007699 |
| drosophila_melanogaster | Golgin84 | FBGN0039188 |
| caenorhabditis_elegans | golg-5 | WBGENE00011975 |
Protein
Protein identifiers
Golgin subfamily A member 5 — Q8TBA6 (reviewed: Q8TBA6)
Alternative names: Cell proliferation-inducing gene 31 protein, Golgin-84, Protein Ret-II, RET-fused gene 5 protein
All UniProt accessions (2): Q8TBA6, H0YK03
UniProt curated annotations — full annotation on UniProt →
Function. Involved in maintaining Golgi structure. Stimulates the formation of Golgi stacks and ribbons. Involved in intra-Golgi retrograde transport.
Subunit / interactions. Homodimer. Interacts with RAB1A that has been activated by GTP-binding, and possibly also with OCRL1. Interacts with isoform CASP of CUX1.
Subcellular location. Golgi apparatus membrane.
Tissue specificity. Ubiquitous. Highly expressed in seminiferous tubules and Leydig cells in testis, and detected at much lower levels in the other tissues tested. Expression is very low or not detectable in spermatozoa.
Post-translational modifications. Highly phosphorylated during mitosis. Phosphorylation is barely detectable during interphase.
Disease relevance. A chromosomal aberration involving GOLGA5 is found in papillary thyroid carcinomas (PTCs). Translocation t(10;14)(q11;q32) with RET. The translocation generates the RET/GOLGA5 (PTC5) oncogene.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TBA6-1 | 1 | yes |
| Q8TBA6-2 | 2 |
RefSeq proteins (1): NP_005104* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019177 | Golgin_subfamily_A_member_5 | Family |
Pfam: PF09787
UniProt features (21 total): compositionally biased region 4, modified residue 3, splice variant 2, sequence variant 2, sequence conflict 2, topological domain 2, initiator methionine 1, chain 1, site 1, transmembrane region 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TBA6-F1 | 72.60 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 497–498 (breakpoint for translocation to form ret-golga5 oncogene)
Post-translational modifications (3): 2, 89, 116
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6811438 | Intra-Golgi traffic |
MSigDB gene sets: 130 (showing top):
MODULE_255, MODULE_317, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOMF_GTPASE_BINDING, GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT, DAWSON_METHYLATED_IN_LYMPHOMA_TCL1, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, E4F1_Q6, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, DANG_BOUND_BY_MYC, chr14q32, GOBP_GOLGI_ORGANIZATION, GOCC_GOLGI_STACK, GOCC_GOLGI_CISTERNA
GO Biological Process (3): retrograde transport, vesicle recycling within Golgi (GO:0000301), Golgi organization (GO:0007030), Golgi vesicle transport (GO:0048193)
GO Molecular Function (2): small GTPase binding (GO:0031267), protein homodimerization activity (GO:0042803)
GO Cellular Component (6): Golgi membrane (GO:0000139), Golgi apparatus (GO:0005794), cis-Golgi network (GO:0005801), membrane (GO:0016020), transport vesicle (GO:0030133), Golgi cisterna (GO:0031985)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Intra-Golgi and retrograde Golgi-to-ER traffic | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| Golgi apparatus | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| intra-Golgi vesicle-mediated transport | 1 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| vesicle-mediated transport | 1 |
| GTPase binding | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| bounding membrane of organelle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| cytoplasmic vesicle | 1 |
| Golgi stack | 1 |
| Golgi apparatus subcompartment | 1 |
Protein interactions and networks
STRING
1034 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GOLGA5 | COG7 | P83436 | 930 |
| GOLGA5 | GOLGB1 | Q14789 | 920 |
| GOLGA5 | CUX1 | P39880 | 778 |
| GOLGA5 | GORASP1 | Q9BQQ3 | 773 |
| GOLGA5 | OCRL | Q01968 | 766 |
| GOLGA5 | TRIP11 | Q15643 | 739 |
| GOLGA5 | COG3 | Q96JB2 | 731 |
| GOLGA5 | COG8 | Q96MW5 | 709 |
| GOLGA5 | RAB1A | P11476 | 693 |
| GOLGA5 | BLZF1 | Q9H2G9 | 693 |
| GOLGA5 | GOLGA2 | Q08379 | 692 |
| GOLGA5 | GORASP2 | Q9H8Y8 | 683 |
| GOLGA5 | TRIM33 | Q9UPN9 | 683 |
| GOLGA5 | COG5 | Q9UP83 | 668 |
| GOLGA5 | COG6 | Q9Y2V7 | 646 |
IntAct
229 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| CD27 | TCAF2 | psi-mi:“MI:0914”(association) | 0.640 |
| CHST14 | CANX | psi-mi:“MI:0914”(association) | 0.640 |
| NIPAL1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.640 |
| CERS2 | ATP5F1B | psi-mi:“MI:0914”(association) | 0.640 |
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| IPPK | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| C3AR1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| POMK | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| HTR2C | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| B4GALT3 | SLC19A2 | psi-mi:“MI:0914”(association) | 0.530 |
| SPINT2 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC107 | PLD2 | psi-mi:“MI:0914”(association) | 0.530 |
| SPPL2B | UQCRQ | psi-mi:“MI:0914”(association) | 0.530 |
| ODAD3 | CCDC22 | psi-mi:“MI:0914”(association) | 0.530 |
| GPR161 | USP12 | psi-mi:“MI:0914”(association) | 0.530 |
| ASGR2 | MT-CO1 | psi-mi:“MI:0914”(association) | 0.530 |
| STS | GJA1 | psi-mi:“MI:0914”(association) | 0.530 |
| AOC2 | GOLGA5 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM9 | ESYT2 | psi-mi:“MI:0914”(association) | 0.530 |
| YIPF3 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (349): GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Proximity Label-MS), GOLGA5 (Proximity Label-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS)
ESM2 similar proteins: B0WPU9, B3MNR6, B3NL60, B4G831, B4I5P7, B4N1C2, B4PAF2, B4Q9E6, B6MFW3, F1MA98, F6ZDS4, G0SA56, O61493, O76878, P12270, P16568, P70403, P85001, Q13948, Q17AF4, Q24185, Q29N92, Q2T9W6, Q3ZU82, Q4V7E8, Q4WDD7, Q5EE04, Q5R8V1, Q5TZ80, Q5ZJ27, Q6GNT7, Q6GQ73, Q6IR70, Q6NRB0, Q6ZMI0, Q7PWT9, Q7SXE4, Q86VS8, Q8BIL5, Q8BUK6
Diamond homologs: Q3ZU82, Q5JLY8, Q6GNT7, Q7SXE4, Q8S8N9, Q8SZ63, Q8TBA6, Q9QYE6, B0F9L7
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 220 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Class A/1 (Rhodopsin-like receptors) | 15 | 7.0× | 2e-06 |
| COPII-mediated vesicle transport | 6 | 6.2× | 1e-02 |
| GPCR ligand binding | 15 | 6.1× | 7e-06 |
| Signaling by GPCR | 15 | 3.8× | 1e-03 |
| GPCR downstream signalling | 13 | 3.6× | 4e-03 |
| G alpha (i) signalling events | 14 | 3.5× | 3e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| Golgi to plasma membrane transport | 6 | 16.7× | 4e-04 |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 10 | 10.8× | 3e-05 |
| endocytic recycling | 7 | 9.3× | 2e-03 |
| positive regulation of cytosolic calcium ion concentration | 11 | 6.4× | 4e-04 |
| phospholipase C-activating G protein-coupled receptor signaling pathway | 9 | 5.9× | 4e-03 |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 10 | 5.6× | 2e-03 |
| protein transport | 20 | 4.3× | 3e-05 |
| G protein-coupled receptor signaling pathway | 21 | 3.8× | 9e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
110 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 87 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2311 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:92797403:TACA:T | acceptor_loss | 1.0000 |
| 14:92797405:CA:C | acceptor_loss | 1.0000 |
| 14:92797406:A:AC | acceptor_loss | 1.0000 |
| 14:92797407:G:C | acceptor_loss | 1.0000 |
| 14:92806734:A:AC | acceptor_loss | 1.0000 |
| 14:92806734:A:AG | acceptor_gain | 1.0000 |
| 14:92806735:G:GT | acceptor_gain | 1.0000 |
| 14:92806735:GA:G | acceptor_gain | 1.0000 |
| 14:92806735:GAA:G | acceptor_gain | 1.0000 |
| 14:92806735:GAAGC:G | acceptor_gain | 1.0000 |
| 14:92806896:G:GT | donor_gain | 1.0000 |
| 14:92806897:A:T | donor_gain | 1.0000 |
| 14:92806900:G:GT | donor_gain | 1.0000 |
| 14:92806904:T:G | donor_gain | 1.0000 |
| 14:92806960:GAAG:G | donor_gain | 1.0000 |
| 14:92806961:A:T | donor_gain | 1.0000 |
| 14:92809298:A:AG | acceptor_gain | 1.0000 |
| 14:92809299:G:GG | acceptor_gain | 1.0000 |
| 14:92809518:CGGTA:C | donor_loss | 1.0000 |
| 14:92809520:G:GA | donor_loss | 1.0000 |
| 14:92809520:G:GG | donor_gain | 1.0000 |
| 14:92809521:T:G | donor_loss | 1.0000 |
| 14:92810252:A:AG | acceptor_gain | 1.0000 |
| 14:92810253:G:A | acceptor_loss | 1.0000 |
| 14:92810253:G:GG | acceptor_gain | 1.0000 |
| 14:92810253:GA:G | acceptor_gain | 1.0000 |
| 14:92810253:GAAT:G | acceptor_gain | 1.0000 |
| 14:92810253:GAATA:G | acceptor_gain | 1.0000 |
| 14:92810358:A:T | donor_gain | 1.0000 |
| 14:92811549:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
4822 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:92811750:T:C | L439P | 1.000 |
| 14:92833183:T:C | L594P | 1.000 |
| 14:92833195:T:C | L598P | 1.000 |
| 14:92797481:T:C | L15S | 0.999 |
| 14:92811737:G:C | A435P | 0.999 |
| 14:92811738:C:A | A435D | 0.999 |
| 14:92816251:T:C | S441P | 0.999 |
| 14:92833171:G:C | R590P | 0.999 |
| 14:92833174:T:C | L591P | 0.999 |
| 14:92833207:A:C | Q602P | 0.999 |
| 14:92833225:T:C | L608P | 0.999 |
| 14:92835643:C:A | A677D | 0.999 |
| 14:92835652:T:A | I680N | 0.999 |
| 14:92837406:T:C | L691P | 0.999 |
| 14:92839381:T:A | W711R | 0.999 |
| 14:92839381:T:C | W711R | 0.999 |
| 14:92797460:C:A | A8D | 0.998 |
| 14:92809458:G:C | A311P | 0.998 |
| 14:92816256:G:C | K442N | 0.998 |
| 14:92816256:G:T | K442N | 0.998 |
| 14:92824634:T:C | L570P | 0.998 |
| 14:92833246:T:C | L615P | 0.998 |
| 14:92833258:T:C | L619P | 0.998 |
| 14:92835640:C:A | A676D | 0.998 |
| 14:92835655:A:C | D681A | 0.998 |
| 14:92835655:A:T | D681V | 0.998 |
| 14:92837394:T:C | L687P | 0.998 |
| 14:92837396:G:A | G688R | 0.998 |
| 14:92837396:G:C | G688R | 0.998 |
| 14:92837397:G:A | G688E | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000028225 (14:92831992 T>G), RS1000042338 (14:92795931 C>G), RS1000109764 (14:92798848 C>A,T), RS1000157705 (14:92835902 A>G), RS1000199042 (14:92793733 A>G), RS1000222328 (14:92833895 TA>T,TAA), RS1000240339 (14:92804938 G>A,T), RS1000253379 (14:92825684 G>C), RS1000293082 (14:92835435 T>C), RS1000442117 (14:92802999 T>G), RS1000532377 (14:92837233 A>G), RS1000625676 (14:92837005 A>G), RS1000644598 (14:92794570 C>G), RS1000651000 (14:92797370 C>T), RS1000655002 (14:92796068 C>T)
Disease associations
OMIM: gene MIM:606918 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_7 | Body mass index | 4.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 3 |
| Cyclosporine | increases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| afimoxifene | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Manganese | affects expression | 1 |
| Nickel | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Raloxifene Hydrochloride | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2XZ | Abcam HEK293T GOLGA5 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.